A new study underway in Seattle aims to answer that — and related questions —…
emcguinnSeptember 29, 2020
In a large randomized clinical trial, researchers evaluated the immunotherapy drug avelumab for patients with advanced urothelial…
emcguinnSeptember 25, 2020
Dr. Tyler Starr was standing in the hallway outside his lab, nursing a coffee and…
emcguinnSeptember 24, 2020
For the nearly 17 million U.S. college students and their teachers who recently started back…
emcguinnSeptember 24, 2020
Seattle Genetics, Inc. and Astellas Pharma Inc. today announced that a phase 3 trial of…
emcguinnSeptember 23, 2020
More than 5 million Americans have Alzheimer’s disease, and the number is projected to rise to nearly…
emcguinnSeptember 22, 2020
Multiple sclerosis (MS) is extremely difficult to study because the structure the immune system attacks…
emcguinnSeptember 22, 2020
Picture the route a car might take through a city. To reach the other side…
eabramovichSeptember 18, 2020
A new approach to predicting which babies will develop type 1 diabetes (T1D) — which…
eabramovichSeptember 18, 2020
